A detailed history of Alpha Core Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Alpha Core Capital LLC holds 55,222 shares of PFE stock, worth $1.38 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
55,222
Previous 54,597 1.14%
Holding current value
$1.38 Million
Previous $1.53 Million 4.65%
% of portfolio
0.37%
Previous 0.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $17,312 - $19,618
625 Added 1.14%
55,222 $1.6 Million
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $435,052 - $509,800
-17,223 Reduced 23.98%
54,597 $1.53 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $29,851 - $34,278
-1,153 Reduced 1.58%
71,820 $1.99 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $272,013 - $353,315
10,410 Added 16.64%
72,973 $2.1 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $78,845 - $92,162
2,457 Added 4.09%
62,563 $2.08 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $1.22 Million - $1.41 Million
33,831 Added 128.76%
60,106 $2.2 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $25,603 - $33,332
650 Added 2.54%
26,275 $1.07 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $71,309 - $93,086
1,708 Added 7.14%
25,625 $1.31 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $193,506 - $236,223
4,422 Added 22.68%
23,917 $1.05 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $138,333 - $164,020
2,973 Added 17.99%
19,495 $1.02 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $755,881 - $936,632
16,522 New
16,522 $855,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $223,580 - $271,236
-7,423 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $244,365 - $277,323
7,423 New
7,423 $291,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Alpha Core Capital LLC Portfolio

Follow Alpha Core Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Core Capital LLC with notifications on news.